Insmed (INSM) return on equity (ROE)

Return on equity · fiscal 2025
-172.8%

Insmed (INSM) earned a return on equity of -172.8% in fiscal 2025 (the year ended December 31, 2025). That is 147.4 percentage points higher than the -320.2% of fiscal 2024. Figures as of 17 Nov 2026, 23:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-172.8%
Change on fiscal 2024
+147.4 pts
Highest on record
95.5%fiscal 2009
Lowest on record
-547.5%fiscal 2022
Fiscal years on record
162009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Insmed return on equity (ROE), in more detail

Across the 16 fiscal years on record (2009–2025), the highest was 95.5% in fiscal 2009 and the lowest -547.5% in fiscal 2022. The fiscal 2025 figure is higher than in 13% of the 15 earlier fiscal years on record, whose median is -53.4%.

History · 16 fiscal years

Return on equity by fiscal year

Insmed return on equity (ROE), year by year

Insmed (INSM) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-172.8% 147.4 pts up
2024-320.2%—
2022-547.5% 441.6 pts down
2021-105.9% 0.7 pts up
2020-106.6% 9.4 pts down
2019-97.2% 58.5 pts up
2018-155.7% 102.3 pts down
2017-53.4% 60.7 pts up
2016-114.1% 76.2 pts down
2015-37.9% 4.6 pts up
2014-42.5% 3.4 pts down
2013-39.1% 4.9 pts down
2012-34.2% 10.2 pts up
2011-44.4% 41.1 pts down
2010-3.3% 98.8 pts down
200995.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Insmed and comparable companies
CompanyReturn on equityFiscal year
STERIS STE10.9%2026
Insmed INSM-172.8%2025
United Therapeutics UTHR18.8%2025
Incyte INCY24.9%2025
Viatris VTRS-23.9%2025
Tenet Healthcare THC33.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on INSM

Insmed, figure by figure

Insmed (INSM) overview: price, valuation and scorecardAll health care companies by market value

Insmed return on equity (ROE): questions and answers

What is Insmed's return on equity?

Insmed (INSM) earned a return on equity of -172.8% in fiscal 2025 (the year ended December 31, 2025). That is 147.4 percentage points higher than the -320.2% of fiscal 2024.

Is Insmed's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 13% of the 15 earlier fiscal years on record, whose median is -53.4%.

What are the highest and lowest return on equity figures on record for Insmed?

Across the 16 fiscal years on record (2009–2025), the highest was 95.5% in fiscal 2009 and the lowest -547.5% in fiscal 2022.

How is Insmed's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insmed (INSM) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/INSM/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.